arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1806.00128q-bio.NC
收藏

脑网络揭示抗精神病药物对精神分裂症患者和对照的影响

Brain networks reveal the effects of antipsychotic drugs on schizophrenia patients and controls

Emma K. Towlson, Petra E. Vértes, Ulrich Müller, Sebastian E. Ahnert

摘要:

脑网络的研究,包括来自功能神经成像数据,吸引了广泛的兴趣,并代表了一个快速增长的跨学科领域。将健康志愿者的网络与患者的网络进行比较,可能会提供新的定量诊断方法,以及更好地理解大脑和精神疾病的框架。我们通过网络措施探索静息状态的功能磁共振成像数据,并证明,不仅有一个独特的网络结构,在健康的大脑中,精神分裂症是中断,而且这两个网络响应药物。我们构建了代表15名健康个体和12名精神分裂症患者(男性和女性)的网络,所有这些患者都接受了三种药物治疗:(i)安慰剂;和两种抗精神病药物(ii)阿立哌唑和(iii)舒必利。我们首先重现了既定的发现,即与对照组相比,精神分裂症患者的大脑网络表现出更高的效率和更少的聚类。然后,我们的数据显示,抗精神病药物减轻了这种影响,将指标转移到健康志愿者中观察到的指标,两种药物之间的疗效存在显着差异。此外,我们发现阿立哌唑大大改变了健康对照组的网络统计数据。使用认知能力测试,我们确定阿立哌唑也会对他们的表现产生不利影响。这提供了证据,表明宏观大脑网络结构的变化会导致可测量的行为差异。这是第一次以这种方式评估不同的药物。我们的研究结果奠定了基础,一个客观的方法来计算和比较不同的治疗精神和大脑疾病的疗效。

英文摘要:

The study of brain networks, including derived from functional neuroimaging data, attracts broad interest and represents a rapidly growing interdisciplinary field. Comparing networks of healthy volunteers with those of patients can potentially offer new, quantitative diagnostic methods, and a framework for better understanding brain and mind disorders. We explore resting state fMRI data through network measures, and demonstrate that not only is there a distinctive network architecture in the healthy brain that is disrupted in schizophrenia, but also that both networks respond to medication. We construct networks representing 15 healthy individuals and 12 schizophrenia patients (males and females), all of whom are administered three drug treatments: (i) a placebo; and two antipsychotic medications (ii) aripiprazole and; (iii) sulpiride. We first reproduce the established finding that brain networks of schizophrenia patients exhibit increased efficiency and reduced clustering compared to controls. Our data then reveals that the antipsychotic medications mitigate this effect, shifting the metrics towards those observed in healthy volunteers, with a marked difference in efficacy between the two drugs. Additionally, we find that aripiprazole considerably alters the network statistics of healthy controls. Using a test of cognitive ability, we establish that aripiprazole also adversely affects their performance. This provides evidence that changes to macroscopic brain network architecture result in measurable behavioural differences. This is the first time different medications have been assessed in this way. Our results lay the groundwork for an objective methodology with which to calculate and compare the efficacy of different treatments of mind and brain disorders.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑